A phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIs

Ji Soo Park, Min Hee Hong, You Jin Chun, Hye Ryun Kim, Byoung Chul Cho

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Fingerprint Dive into the research topics of 'A phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIs'. Together they form a unique fingerprint.

Medicine & Life Sciences